StartUp Studio is MARKETS & LISTING's incubator program....
What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio.
What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio.
What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio What is StartUp Studio.
StartUp Studio is very proud to have been and to continue being the Operating Partner to AGS SAS. As StartUp Studio played a key role in the creation of the company, it is delighted to be a close partner in leadership and support to AGS until this day.
AGS is the first project incubated, created and supported through StartUp Studio.
About AGS
AGS, based in Paris, France, is a group of interrelated companies developing biomedicines based on extracellular vesicles from microalgae (MEVs) as a safe, targeted and highly versatile delivery system for innovative biologics, such as mRNA, siRNA, miRNA, proteins, peptides and oligonucleotides for a broad range of human diseases.
AGS-M, a contract development and manufacturing organization, produces the MEVs needed to support preclinical and clinical development of MEV-based product pipelines from AGS Therapeutics, and from pharmaceutical and other companies partnering with AGS.
AGS’ MEVs are derived from Chlorella, a 2-billion-year-old single-cell algae used for decades as a food supplement. AGS’ MEVs are easy to manufacture in large quantities with simple cell culture media production techniques that are both eco-friendly and easily scalable.
For more information visit www.ags-tx.com and www.ags-m.com.
StartUp Studio is currently seeking for its second potential major project.
With the ambition of founding / supporting / building a project as bold and groundbreaking as AGS, StartUp Studio will continue pursuing its selective research and take the necessary time needed to do so.
M&L StartUp Studio leverages the longstanding expertise and the industry network of MARKETS & LISTING's partners in the biotech sector.
As entrepreneurs, company founders and company leaders, MARKETS & LISTING's partners embrace the challenge of selecting outstanding science and technologies in the biomedical sector and lead them into both competitive products and promising biotech businesses.
We focus on a handful, highly selected and ground-breaking projects only. Projects aimed at changing the paradigms in their specific sectors, projects based on disruptive thinking, that address high unmet medical needs and high value markets.
MARKETS & LISTING gets proactively involved in company creation, and follows with committing to leading, strategically and operationally, the newly created company - through the usually tough initial phases and beyond whenever agreeable.
Ongoing project : AGS
ONGOING PROJECT : AGS SAS
AGS is the first project incubated, created and supported by M&L StartUp Studio.
We are very proud to have been at the crossroads in the genesis of AGS and to continue being involved in the leadership and ongoing operational support to AGS.
For more information visit www.ags-tx.com and www.ags-m.com.
Future projects
FUTURE PROJECTS
We are currently exploring and aiming to discover what will be the next project in its StartUp Studio portfolio. We seek a project as bold and groundbreaking as AGS and will allow ourselves the time it requires to find it.